Based on the clinical advice of experts, for the first cohort, the applicant limited the analysis to cases assigned to MS DRGs 846 (Chemotherapy Without Acute Leukemia as Secondary Diagnosis with MCC), 847 (Chemotherapy Without Acute Leukemia as Secondary Diagnosis with CC) and 848 (Chemotherapy Without Acute Leukemia as Secondary Diagnosis without CC/MCC), because the experts believed that TECVAYLI TM would mostly likely be administered in cases assigned to these MS DRGs
Dawi J, Misakyan Y, Affa S, Kades S, Narasimhan A, Hajjar F, et al
Although there was a clear trend for a higher Firmicutes : Bacteroidetes ratio in the WD control group relative to the LD control group, this difference did not rise to the level of statistical significance
If you are looking for a great place to get your meds online, this is the place